Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare MutationsContributed by: Business WireLogoTagsBiotechnologyPharmaceuticalGeneticsHealthKAFTRIO